Predicting immune checkpoint therapy response in three independent metastatic melanoma cohorts.
Szadai L, Bartha A, Parada IP, Lakatos AIT, Pál DMP, Lengyel AS, de Almeida NP, Jánosi ÁJ, Nogueira F, Szeitz B, Doma V, Woldmar N, Guedes J, Ujfaludi Z, Pahi ZG, Pankotai T, Kim Y, Győrffy B, Baldetorp B, Welinder C, Szasz AM, Betancourt L, Gil J, Appelqvist R, Kwon HJ, Kárpáti S, Kuras M, Murillo JR, Németh IB, Malm J, Fenyö D, Pawłowski K, Horvatovich P, Wieslander E, Kemény LV, Domont G, Marko-Varga G, Sanchez A.
Szadai L, et al. Among authors: pal dmp.
Front Oncol. 2024 Jul 2;14:1428182. doi: 10.3389/fonc.2024.1428182. eCollection 2024.
Front Oncol. 2024.
PMID: 39015503
Free PMC article.